UnitedHealth Group's Stock Surge Linked to Strategic Membership Changes
UnitedHealth Group (UNH) has seen its stock rise about 40% since late March 2026, a notable increase compared to the S&P 500's nearly 19% gain. This surge was not unexpected, as the company had previously indicated its intention to adjust its membership strategy to improve profit margins. In July 2025, UnitedHealth announced that its pricing for 2026 would focus on margin recovery, which included exiting plans serving over 600,000 members, primarily from less managed products like PPO offerings, and narrowing its Medicare Advantage networks.
The need for recovery was evident. As of fiscal Q4 2025, UnitedHealth's trailing twelve-month operating margin stood at 4.2%, significantly lower than its three-year average of 7.8%. Despite a revenue growth of 11.8% over the same period, medical costs had outpaced premiums, indicating that pricing adjustments were necessary.
For Your Trading Desk
Sponsor Spike Success.
By October 2025, the company reported that its repricing efforts were on track to enhance operating earnings for 2026 through improved margins. In January 2026, UnitedHealth projected a contraction in Medicare Advantage membership by 1.3 million to 1.4 million, a move aimed at favoring margin recovery while targeting nearly $1 billion in operating cost reductions.
The results of these strategies have begun to materialize. In fiscal Q2 2026, adjusted earnings per share reached $6.38, up from $4.08 a year earlier. With the stock already on an upward trajectory, the company raised its full-year adjusted earnings outlook for 2026 to between $19.50 and $20 per share, up from a previous estimate of over $17.75. This improvement was not driven by increased sales but rather by the operational adjustments made in benefit design and care management.
Medicare Cost Projections and Enrollment Trends Signal Strategic Adjustments
Looking ahead, Medicare medical cost growth for 2026 is now expected to be below the initial estimate of around 10%. Management credits this reduction to its own benefit design and care management strategies. The anticipated decline in Medicare Advantage enrollment is now projected to be about 1.1 million for 2026, which is less than the earlier estimates.
The timing of these changes was crucial. Implied volatility on UNH options surged from the 37th percentile of its trailing one-year range in early February 2026 to the 91st by mid-March, indicating that a significant price movement was anticipated. However, the direction of this movement remained uncertain.
Competitive Landscape and Future Challenges for UnitedHealth Group
UnitedHealth's success has not been isolated. Elevance Health (ELV) also reported a return of 40.3%, slightly surpassing UnitedHealth's performance, while CVS Health (CVS) and Cigna (CI) returned 24.0% and 5.9%, respectively, during the same period. This suggests that early recognition of UnitedHealth's strategic plan did not yield significantly better returns than its closest competitors.
Despite these positive developments, challenges remain, particularly in the commercial sector, where full margin recovery is not expected until after 2027. Investors should monitor how UnitedHealth executes its plans moving forward, as the market continues to evaluate the effectiveness of its strategies.




